Covera-HS, a new timed-release verapamil designed for BEDTIME dosing
April 1996
Searle will soon launch Covera-HS, a new timed-release verapamil designed for BEDTIME dosing.
It's approved for either hypertension or angina.
The idea is to provide peak effects in the MORNING when blood pressure and heart rate tend to be highest...and patients are most vulnerable to chest pain or a heart attack.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote